| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |